Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development

2 hours ago 1

Abdul Rahman

Sun, April 19, 2026 astatine 3:51 PM CDT 2 min read

Simulations Plus Inc (NASDAQ:SLP) is among the champion aesculapian AI stocks to bargain now. On March 26, Simulations Plus announced collaboration programs for AI-enabled modeling successful cause development. Simulations Plus uses AI to assistance scientists summation ratio successful their modeling workflow.

Here’s Simulations Plus Inc (SLP)’s Vision for AI successful  Drug Development

Here’s Simulations Plus Inc (SLP)’s Vision for AI successful Drug Development

The institution said 3 ample pharmaceutical companies were participating successful its collaboration programs. Back successful January, during the Simulations Plus capitalist time event, CEO Shawn O’Connor noted that for AI to fulfill its imaginable successful cause development, it needs to beryllium delivered responsibly, beryllium grounded successful validated science, and integrated into existent workflows.

Simulations Plus says that companies participating successful its collaboration programs volition integrate its AI agents straight into their modeling workflows. The institution favors a deployment attack that infuses AI into the implicit strategy alternatively than offering it arsenic a standalone capability.

For its fiscal Q2 2026 ended February 28, Simulations Plus delivered fiscal results that surpassed expectations. The results, which were released connected April 10, showed EPS of $0.35, which improved from $0.31 successful the anterior twelvemonth and bushed the statement estimation of $0.31.

Revenue roseate 8% YoY to $24.3 cardinal and came supra the statement forecast of $21.66 million. The institution reported income maturation successful some its bundle and services segments. The bundle concern accounts for 60% of full revenue, with the remainder coming from the services business.

For the fiscal 2026 full-year, Simulations Plus anticipates gross successful the set of $79 cardinal to $82 million, suggesting a imaginable maturation of up to 4%. It expects adjusted EPS successful the scope of $0.75 – $0.85.

Simulations Plus Inc (NASDAQ:SLP) provides modeling and simulation bundle utilized by pharmaceutical and biotechnology companies. Simulations Plus besides offers consulting services. Its solutions are aimed astatine helping scientists to velocity up cause improvement and trim costs.

While we admit the imaginable of SLP arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: David Abrams’ Hedge Fund Is Betting On These 8 Stocks and 10 Best Energy Storage Stocks to Buy According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article